Glimisave MV 2.3 Tablet SR

Glimisave MV 2.3 Tablet SR is a combination medicine prescribed for the management of type 2 diabetes mellitus. It helps in keeping blood sugar levels under control by targeting different mechanisms—stimulating insulin secretion, lowering sugar production in the liver, improving insulin action, and slowing down the absorption of carbohydrates from food.

The sustained-release (SR) form provides a steady effect, supporting better day-long glucose management. It is generally recommended along with proper diet and exercise for effective diabetes care.

Key Highlights

• Triple action formula for improved blood sugar regulation

• Sustained release ensures long-lasting effect

• Helps lower the risk of diabetes-related complications

• Works best when taken with meals

Possible Side Effects
Some users may notice digestive discomfort such as bloating, diarrhea, or abdominal pain, along with dizziness or mild weakness in certain cases. Usually, these settle down as the body adjusts.

How it Works
This tablet combines Glimepiride, Metformin, and Voglibose. Glimepiride enhances insulin release, Metformin reduces hepatic glucose production and increases insulin sensitivity, while Voglibose delays carbohydrate breakdown, preventing sudden glucose spikes.